Virtu Financial’s Atea Pharmaceuticals AVIR Stock Holding History

Virtu Financial’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$183K	Buy	+34,030	New	+$156K	0.01%	1048
2024 Q4	–	Sell	-29,491	Closed	-$99K	–	1540
2024 Q3	$99K	Buy	+29,491	New	+$107K	0.01%	911
2022 Q4	–	Sell	-30,693	Closed	-$175K	–	1591
2022 Q3	$175K	Buy	+30,693	New	+$235K	0.02%	914
2021 Q4	–	Sell	-26,522	Closed	-$930K	–	1701
2021 Q3	$930K	Buy	+26,522	New	+$736K	0.08%	254
2021 Q2	–	Sell	-5,626	Closed	-$347K	–	1500
2021 Q1	$347K	Buy	+5,626	New	+$380K	0.02%	724

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtu Financial's AVIR Position: Q1 2026 in Review

Virtu Financial opened a new position in Atea Pharmaceuticals (AVIR) in Q1 2026: 34,030 shares worth $183K. The stake represents 0.01% of the portfolio and ranks #1048 among its holdings. This is a return to the name: Virtu Financial previously reported a position in AVIR as recently as Q3 2024.

Virtu Financial first reported a position in AVIR in Q1 2021 and has held it in 5 quarters since. The position peaked at $930K in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

Virtu Financial held 34,030 shares of Atea Pharmaceuticals worth $183K as of Q1 2026.
Atea Pharmaceuticals was a new Virtu Financial position in Q1 2026.
Atea Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #1048 holding.
Virtu Financial first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
Virtu Financial's Atea Pharmaceuticals position peaked at $930K in Q3 2021.
127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.